Author of the article:
March 25, 2025 was published • He read 5 minutes
Item content
Toronto, March 25, 2025 (Globe Newswire) – PSYENCE GROUP INC (“Infantry“Or” or “Company“) (CSE: PSYG), NASDAQ listed associates, PSYENCE Biomedical Ltd (NASDAQ: PBM) (“Pbm“Or” or “Psyence biomed“), This is the expansion of a newly established Scientific Advisory Council (SAB), which is a well-known leader in psychopycology.
Item content
Item content
According to a report, the University of Dr. Stein Cape Town (UCT) is a professor and chairman of the Department of Psychiatry and Mental Health, Southern African Medical Research Council (MRC), Professor and Department of Risk and Sustainability. Dr. Stein, SOON chairman Albert P. Garcia-Romeu, Ph.D, psychiatric and behavioral branches will work closely with Associate Professor, Johns Hopkins University Medical Faculty. PBM reports that PBM’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN’s PSILOCKYBIN will develop the application of psilokybin-based therapeutic therapeutic therapeutic therapeutics plans.
Ad 2
Item content
PBM will discuss April 10, 2025, on a corporate webinar in a corporate webinar to discuss the PBM’s wider visibility for the future of PBC therapeutic therapeutics.
To register for the Corporate Webinar, visit the following link: Psyence Biomed Corporate Webinar
The company gave a total of 9,034,487 restricted sharing units (each “)Rdu“) According to the company’s RSO plan, the company represents a total share in each RSU of RSU, in accordance with the company’s RSU plan in accordance with RSU plan.
About Psyence Group and Psyence Biomed:
PSYence Group is a life scientific biotechnology company based on the Canadian Securities Exchange (CSE: PSYG), Natural Psychics. Psyence Biomed, Botanika (non-psychological traumatic drugs, Psilosic Trauma, Psychological Trauma and Psychological Trauma, Psychological Trauma and Psychological Trauma and its psychological trauma and its psychological trauma and its psychological trauma are the world’s first life-based psychological trauma. To make our obligation combines psychic and science words to confirm our commitment.
The best stories
Item content
Advertising 3
Item content
Ruered by nature and science, PSYence Group, works to develop advanced natural Psilosos products for clinical research and development.
Learn more information at www.psyence.com.
Learn more www.psyencebiomed.com and LinkedIn.
Contact Information for Psyence Group
Email: IR@psyence.com
Media surveys: Media@psyence.com
General information: info@psyence.com
Phone: +1 416-477708
Information about contact for Psyence Biomed
Email: IR@psyengbiomed.com
Media surveys: media@pypyencebiomed.com
General information: info@psyencebiomed.com
Phone: +1 416-477708
Contact Investment:
Michael Kydd
Investor Relations Advisor michael@psigencebiomed.com
Forward-looking phrases
This communication includes “forward-looking phrases” within the meaning of securities legislation. Such expressions are not limited, but are not limited, the expectations and intentions related to future transactions, products and services; “Most likely,” “Expected”, “” Expected “,” “Expected”, “” “Expected,” “” “Plan” “” Plan “” “Plan” “” Plan “” “” Planning, “” Plan “” “Plan” “” Plan “” “Plan” “” Planning “is expected.”
Advertising 4
Item content
Following the statements of the PBM pallicybin phaium in this communication, the statement of the IIB clinical test and second to the second. These forward-looking phrases are based on a number of assumptions, including those who will not have any delay in the implementation of PBM pallicinbin phase and will not have enough resources to continue the second sign of the PBM.
There are many risk and uncertainty that can cause these forward-looking phrases or expression of performance to these forward-looking phrases or statements. These risks and uncertainties include the registration of pedestrian biomed to register the total shares of Biomed General Shares: (i) Paspence biomed to register the total shares and guarantees given to the NASDAQ; and (v) changes in various factors, changes in various factors, competitive and highly regulated areas in competitive and highly regulated areas, including changes in the performance changes and Paspas biomed’s work in the capital of Passport Biomed. The above lists of the factors are not exhausted. The above factors and sedanplus.com on Sendiplus.com-A and PBM’s last Avenue (333-284444444444444444444444444444444444444444444444444444444444444444444444444444) You need to carefully review other-depicting risks and uncertainties.Pang“) On January 24, 2025, other documents and future results and future events and future events and future events will be obtained. No one intends to be able to update the following statements, such as speaking from the date.
Advertising 5
Item content
The company does not make claims that bring medical, treatment or health benefits about the company’s offered products. The United States has not evaluated allegations related to food and medicinal administration, health canadian or other similar regulatory bodies psilocybin, psilocybin analogues or other mental compounds or nutrients. The effectiveness of such products has not been confirmed by approved research. There is no guarantee of psilocybin, psilocybin analogues or other psychedized compounds or nutritional compounds or nutrition, treatment, treatment or any disease or situation. Strong scientific research and clinical trials need. The company did not conduct clinical trials for the use of the proposed products. Any reference for the quality, sequence, effectiveness and safety of potential products does not mean that the company will end in clinical trials or completes such trials. If the company cannot affirm approval or research to trade its work, it may have a material negative impact on performance and operations.
Item content
